Dueling Data on Would-Be Covid-19 Treatment Leave Questions
An automated machine at the Gilead Sciences Inc. lab in Foster City, California, U.S. (Photographer: David Paul Morris/Bloomberg)

Dueling Data on Would-Be Covid-19 Treatment Leave Questions

(Bloomberg) -- With dueling data released on Gilead Sciences Inc.’s potential coronavirus drug, the jury remains out on how well the medicine works.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.